Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net gain/(loss)	$ (1,568,639)	$ (1,234,471)
Adjustments to reconcile net (loss) to net cash (used in) operating activities
Fair value of stock options issued	267,647	309,783
Imputed interest	76,091	74,843
Accounts payable and accrued expenses	142,878	(472,398)
Net cash (used in) operating activities	(1,082,023)	(1,322,243)
Cash flows from investing activities
Convertible note receivable - related party		(200,000)
Accrued interest receivable - related party	(14,234)	(3,033)
Cash (used in) investing activities	(14,234)	(203,033)
Cash flows from financing activities
Repayment of notes payable		(600,000)
Repayment of notes payable related party		(150,000)
Net cash (used in) financing activities		(750,000)
Net decrease in cash and cash equivalents	(1,096,257)	(2,275,276)
Cash and cash equivalents, including restricted, beginning of year	1,570,844	3,846,120
Cash and cash equivalents, including restricted, end of period	474,587	1,570,844
Non-cash financing activities
Supplemental disclosure of cash flow information:
Interest
Income taxes